Article metrics

Download PDFPDF

Original research
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000